Long-term reduction in IOP due to uneventful surgical procedures in PXG patients

Article

Pseudoexfoliation glaucoma (PXG) patients who underwent uneventful uneventful phacoemulsification, IOL implantation, and trabeculectomy experienced long-term lower IOP and required fewer medications during 10 years.

Pseudoexfoliation glaucoma (PXG) patients who underwent uneventful uneventful phacoemulsification, IOL implantation, and trabeculectomy experienced long-term lower IOP and required fewer medications during 10 years, claims a paper published in the Journal of Cataract and Refractive Surgery.

Dr Bradford J. Shingleton et al., Center for Eye Research and Education, Boston, Massachusetts, USA, performed a retrospective, comparative case series analysis on consecutive eyes with pseudoexfoliation glaucoma (PXG) that underwent uneventful combined phacoemulsification and trabeculectomy. Change in intraocular pressure (IOP), glaucoma medication requirements and logMAR corrected distance visual acuity was compared between the phaco-only group and the combined surgery group.

Mean IOP and glaucoma medication requirements significantly reduced when patients underwent combined surgery, compared to the phaco-only group. Reduction in mean postoperative IOP was more significant in eyes with a higher mean preoperative IOP. Of the eyes included in the combined-surgery group, 13.8% needed subsequent laser trabeculoplasty, glaucoma surgery or a combination of the two.

Combined surgical procedures lead to long-term reductions in IOP and glaucoma medication requirements, as well as fewer 1-day postoperative spikes.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.